procyanidin has been researched along with Chronic Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumert, TF; Bhaskaran, S; Fauvelle, C; Heydmann, L; Lambotin, M; Moog, C; Prakash, E; Vishwaraman, M | 1 |
| Hattori, T; Inoue, Y; Kodama, EN; Li, S; Matsuura, Y; Tanaka, T; Tani, H; Zhang, J | 1 |
2 other study(ies) available for procyanidin and Chronic Hepatitis C
| Article | Year |
|---|---|
A cinnamon-derived procyanidin type A compound inhibits hepatitis C virus cell entry.
Topics: Antiviral Agents; Biflavonoids; Catechin; Cinnamomum zeylanicum; Dose-Response Relationship, Drug; Hepacivirus; Hepatitis C, Chronic; Humans; Proanthocyanidins | 2017 |
Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication.
Topics: Antiviral Agents; Biflavonoids; Catechin; Cell Line, Tumor; Cinnamomum zeylanicum; Drugs, Chinese Herbal; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Proanthocyanidins; Recombinant Proteins; Replicon; Ribavirin; RNA, Viral; Virus Internalization; Virus Replication | 2010 |